Abstract
The aim of this study was to explore current practice patents for prescribing single versus dual antiplatelet therapy after lower extremity endovascular interventions and to explore the effects of various antiplatelet therapy regimens on 1-year patency and reintervention rates.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
